Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic Shock
Condition(s):Early Phase of Severe Sepsis and Septic ShockLast Updated:September 20, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Early Phase of Severe Sepsis and Septic ShockLast Updated:September 20, 2017Completed
Condition(s):Sepsis; Septic ShockLast Updated:February 6, 2020Unknown status
Condition(s):InfectionLast Updated:April 19, 2018Unknown status
Condition(s):Late-Onset Neonatal SepsisLast Updated:August 8, 2023Recruiting
Condition(s):Enterobacteriaceae InfectionsLast Updated:July 19, 2023Recruiting
Condition(s):ObesityLast Updated:October 26, 2018Completed
Condition(s):Septic Shock; Sepsis; Sepsis SyndromeLast Updated:September 30, 2022Recruiting
Condition(s):Pancreatic Cancer; Pancreas Cancer; Pancreatic DiseasesLast Updated:July 7, 2023Active, not recruiting
Condition(s):Early-Onset Neonatal SepsisLast Updated:October 10, 2023Recruiting
Condition(s):Sepsis; Septic ShockLast Updated:January 11, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.